Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Borel, Nicole ^a   Mukhopadhyay, Sanghamitra ^b,d   Kaiser, Carmen ^a   Sullivan, Erin D ^b   Miller, Richard D ^b   Timms, Peter ^c   Summersgill, James T ^b   Ramirez, Julio A ^b   Pospischil, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Louisville School of Medicine   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CHAPERONIN; ENZYME ANTIBODY; FORMALDEHYDE; GAMMA INTERFERON; NUCLEOSIDE DIPHOSPHATE KINASE; PYRUVATE KINASE;

ARTICLE; BACTERIAL INFECTION; CARDIAC PATIENT; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; FUNCTIONAL PROTEOMICS; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; PERSISTENT INFECTION; PROTEIN EXPRESSION; TISSUE FIXATION; TISSUE MICROARRAY; UPREGULATION;

CELL LINE; CHLAMYDOPHILA; CHLAMYDOPHILA INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS;

EID: 33750403566     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-152     Document Type: Article

References (29)

1. Grayson JT, Kuo CC, Wang SP, Altman J: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986, 315:161-168.
2. Grayston JT: Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992, 15:757-763.
3. Hammerschlng MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J: Persistent infection with Chlamymdia pneumoniae following acute respiratory illness. Clin Infect Dis 1992, 14:178-182.
4. Kuo CC, Jackson LA, Campbell LA, Grayston JT: Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995, 8:451-461.
5. Peeling RW, Brunham RC: Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996, 2:307-319.
6. Saikku P, Mattila K, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serologicall evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, ii:983-986.
7. Saikku P, Leinonen M, Tenkanen L, Ekman MR, Linnanmaki E, Manninen V, Manttari M, Frick MH, Huttimen JK: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992, 116:273-278.
8. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993, 167:841-849.
9. Campbell LS, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK, Grayston JT: Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995, 172:585-588.
10. Ramirez JA, Ahkee S, Summersgill JT, Ganzel BL, Ogden LL, Quinn TC, Gaydos CA, Bobo LL, Hammerschlag MR, Roblin PM, LeBar W, Grayston JT, Kuo CC, Campbell LA, Patton DL, Dean D, Schachter J: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996, 125:979-982.
11. Jackson LA, Campbell LA, Kuo CC, Rodríguez KI, Lee A, Grayston JT: Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997, 176:292-295.
12. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA: Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pre-treated with gamma interferon and tumor necrosis factor alpha. Infect Immun 1995, 36:2801-2803.
13. Holmes EW: Expression and regulation of interferon-gamma-induced tryptophan catabolism in cultured skin fibroblasts. J Interferon Cytokine Res 1998, 18:509-520.
14. Mehta SJ, Miller RD, Ramirez JA, Summersgill JT: Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: role of tryptophan catabolism. J Infect Dis 1998, 177:1326-1331.
15. Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT: Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 2001, 69:7927-7932.
16. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P: Chlamydial persistence: beyond the biphasic paradigm. Infec Immun 2004, 72:1843-1855.
17. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA, Summersgill JT: Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 2002, 70:2976-2981.
18. Mukhopadhyay S, Miller RD, Summersgill JT: Analysis of altered protein expression patterns of Chlamydia pneumoniae by integrated Proteome-Works System. J Proteome Res 2004, 3:878-883.
19. Mukhopadhyay S, Miller RD, Sullivan ED, Theodoropoulos C, Mathews SA, Timms P, Summersgill JT: Protein expression profiles of Chlamydia pneumoniae: persistent vs. heat shock stress response. Infect Immun in press.
20. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
21. Bubendorf L: High-throughput microarray technologies: from genomics to clinics. Eur Urol 2001, 40:231-238.
22. Bubendorf L, Nocito A, Moch H, Sauter G: Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001, 195:72-79.
23. Moch H, Kononen T, Kallioniemi OP, Sauter G: Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001, 8:14-20.
24. Simon R, Mirlacher M, Sauter G: Tissue microarrays. Biotechniques 2004, 36:98-105.
25. Van De Rijn M, Gilks CB: Applications of microarrays to histopathology. Histopathology 2004, 44:97-108.
26. Schraml P, Kononen J, Budendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999, 5:1966-1975.
27. Camp RL, Charette LA, Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000, 80:1943-1949.
28. Mukhopadhyay S, Clark AP, Sullivan ED, Miller RD, Summersgill JT: Detailed protocol for the purification of Chlamydia pneumoniae elementary bodies. J Clin Microbiol 2004, 42:3288-3290.
29. Borel N, Summersgill JT, Mukhopadhyay S, Kaiser C, Nufer L, Miller RD, Ramirez JA, Pospischil A: Persistent Chlamydophila pneumoniae in human coronary atherosclerotic tissue: Tissue Microarray (TMA) analysis and ultrastructural study. In Proceedings of the Eleventh International Symposium on Human Chlamydial Infections: 18-23 June 2006; Niagara-on-the-Lake, Ontario, Canada Edited by: Max Chernesky, Harlan Caldwell, Gunna Christiansen, Ian N Clarke, Bernhard Kaltenboeck, Charles Knirsch, Cho-Chou Kuo, James Mahony, Roger G Rank, Pekka Saikku, Julius Schachter, Walter E Stamm, Richard S Stephens, James T Summersgill, Peter Timms, Priscilla B Wyrick. San Francisco, CA 94110, USA; 2006:567-570.